This invention provides an engineered degradation-resistant HOXB4 protein, materials and methods to produce it, and methods to use this recombinant protein for the ex vivo expansion of hematopoietic stem cells.
[Detail]
Reduces chronic conditions assocated with menopause with an improved safety profile
[Detail]
Intravenous administration of daunorubicin is an FDA-approved drug for the treatment of oncologic malignanciesDaunorubicin induces cell death and suppresses pulmonary artery constriction in a hypoxia-induced animal model of pulmonary hypertensionDaunorubicin mediated suppression of pulmonary artery .....
[Detail]
This invention provides methods of treating and/or preventing ulcerative colitis and colon cancer as well methods of identifying agents that treat and prevent the same.
[Detail]
antibody or protein therapy effective at the cellular leveldecreased possibility of side effects due to high selectivity and identification of a specific targetsuitable for treating a number of respiratory conditions, including asthma, steroid-resistant asthma and COPD
[Detail]
| |< <- | [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] | -> >| |
